Clinical AI: A Prospective Use Case Based on ClearRead CT

Wednesday, March 14th, 2 – 2:45pm EST


  • The role of Clinical Artificial Intelligence in radiology
  • The role of simulation and modeling in product development for Clinical AI
  • Industry insight regarding the commercialization of Clinical AI in Lung Cancer Screening
  • Clinical insight regarding experiences using ClearRead CT, a novel AI application for Chest CT


Photo of doctor watching patient being imaged
Steve Worrell, CEO of Riverain Technologies

Steve is an expert in Clinical AI commercialization and heads up a team of passionate employees dedicated to making a difference in the fight against lung disease using state of the art artificial intelligence.

He has over 25 years of experience, working across engineering, sales and marketing.

Riverain Technologies’ solutions are deployed at leading institutions around the world.

Photo of doctor watching patient being imaged
Dr. Jared Christensen, Division Chief of Cardiothoracic Imaging, Associate Professor of Radiology, Duke University Medical Center

Dr. Christensen is a leading thoracic radiologist dedicated to providing patients with state of the art imaging technology. He has authored a variety of articles on cardiothoracic disease and routinely speaks on topics in lung cancer screening detection, diagnosis, and treatment.

Register to Attend

If you are unable to attend, please register and we will send you the presentation after the webinar.